A Step towards Malaria Vaccine DBP Engagement with DARC of Erythrocyte

Authors

  • Arvind Singh
  • Gaurav Sharma
  • Nakuleshwar Dut Jasuja

DOI:

https://doi.org/10.37591/rrjomv.v7i3.8

Abstract

Plasmodium vivax is causative agent of malaria. In Plasmodium vivax Duffy binding protein (DBP) is most ligand for merozoite invasion of human erythrocyte surface by DARC. Thus, it is most suitable protein for development of vaccine. Initial infection can stop threw malaria vaccine DBP has great role of a family of related proteins found in different malaria species that are found in host cell invasion. There is only reason of malaria diseases in human being is ligand between DBP and DARC. We studied using bioinformatics tool structure which joins DBP to DARC. After many decades of research, there is still zero result ineffective malaria vaccine. We tried to find out a way that target conserved region of DBP to block the PvDBPDARC attachment. Inhibiting of attachment DBP with DARC by monoclonal antibodies or artificial peptide chain same as DBP may lead us a step towards malaria vaccine.

Keywords: Plasmodium vivax, erythrocyte, vaccine

Cite this Article Arvind Singh, Gaurav Sharma, Nakuleshwar Dut Jasuja. A Step towards Malaria Vaccine DBP Engagement with DARC of Erythrocyte. Research & Reviews: A Journal of Microbiology and Virology. 2017; 7(3): 19–26p. 

Downloads

Published

2017-12-04

Issue

Vol. 7 No. 3 (2017)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.